| Grant number: | 21/13951-0 |
| Support Opportunities: | Multi-user Equipment Program |
| Start date: | March 01, 2022 |
| End date: | February 28, 2029 |
| Field of knowledge: | Biological Sciences - Immunology - Immunochemistry |
| Principal Investigator: | Hugo Aguirre Armelin |
| Grantee: | Hugo Aguirre Armelin |
| Host Institution: | Instituto Butantan. São Paulo , SP, Brazil |
| City of the host institution: | São Paulo |
| Associated research grant: | 13/07467-1 - CeTICS - Center of Toxins, Immune-Response and Cell Signaling, AP.CEPID |
| As informações de acesso ao Equipamento Multiusuário são de responsabilidade do Pesquisador responsável | |
| EMU web page: | Página do Equipamento Multiusuário não informada |
| Type of equipment: | Caracterização e Análises de Amostras - Proteínas/Ácidos nuclêicos - PCR |
| Manufacturer: | Fabricante não informado |
| Model: | Modelo não informado |
Abstract
Toxinology and regulation of the lmmune-response are two interconnected classical areas of scientific investigation around which the Butantan lnstitute historically built its strong international reputation. lndeed, it is deeply rooted in the culture of Butantan lnstitute, the notion that toxins are components in complex venoms, which were selected by evolution to exert concerted systemic biological effects through highly specific biochemical, molecular and cellular mechanisms. As a corollary to this notion, isolation and chemical characterization of venom components very likely can yield novel toxin molecules with high therapeutic potential. Following this historical tradition, in the last 10 years, investigators of the Center for Applied Toxinology (CATcepid project) successfully isolated, chemically characterized and patented several novel protein and peptide toxins, which became starting points for development of pharmaceutical innovations in partnership with local industries. This emphasis on proteins and peptides led to deployment of state-of-the-art laboratories for proteomics, transcriptomics, molecular biology of recombinant DNA and peptide synthesis. More recently, studies of biochemical, molecular and cellular mechanisms of hopeful therapeutic drugs were initiated, aiming to establish proofs of concept. Thus, the CAT project has progressively paved the way towards a systems biology oriented center of toxins, immune-response and cell signaling at Butantan lnstitute. The present proposal aims to establish the new Center of Toxins, lmmune-response and Cell Signaling - CeTICS- as a world class center of excellence, taking advantage of the Butantan lnstitute historical international reputation and, also, the research successes and infrastructure legacy of the CATcepid project. To this end 10 investigators, representative of the most competitive leaders of research in the Butantan lnstitute, designed a Center's ambitious research plan focused on integration of subprojects biased towards scientific research and subprojects motivated for technological innovations. A large group of senior scientists from Butantan lnstitute, from other Brazilian institutions and, also, from well-known foreign institutions will be collaborators of the Center. (AU)
| Articles published in Agência FAPESP Newsletter about the research grant: |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |